Paulex Bio Inc.
PrivateLast Round
Seed
Dec 18, 2025
Total Funding Raised
$18.52M
Company Overview
Paulex Bio Inc. is a biotechnology company that develops regeneration therapies for the treatment and prevention of Type-1 and Type-2 Diabetes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Paulex Bio Inc. Comparables
Compare Paulex Bio Inc. with similar companies based on industry and business-model similarity.
Paulex Bio Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 18, 2025 |
Paulex Bio Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LifeSpan Vision Ventures | Seed |
| TCA Venture Group | Seed |
Paulex Bio Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Paulex Bio Inc.'s valuation, stock price, and market status.